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Background: Hepatitis B virus infection (HBV) is one of the most widespread, chronic viral infections in sub-Saharan
Africa, and parts of South America. Therefore, efforts are being made to implement strategies aimed at reducing
the incidence of hepatitis B viral infections. One route of HBV transmission is through unsafe blood transfusion,
which could occur from the use of less sensitive laboratory diagnostic kits. Information on the sensitivity and
specificity of these kits is however limited in many developing countries. This study was therefore performed to
describe the prevalence of HBV infections and also to evaluate the performance of five rapid immunochromatographic
kits commonly used in Ghana.
Methods: A cross-sectional study was designed to describe the prevalence of HBsAg infection and also evaluate the
performance of rapid kits used for screening hepatitis B in the northern part of Ghana.
Results: A total of 164 prospective blood donors were enrolled in this study from January 2012 to December 2013.
The overall true prevalence of HBsAg was 14.6 (95% CI = 9.6 – 21.0). There was no significant association between
transmission related factors and HBV infection. The specificities of all five rapid kits were above 97%, however the
sensitivities and Youden’s indexes were below 60%. A comparison of the reported kit sensitivities to those generated
by this study showed significant difference with the study results being lower than the ones reported in the kit
literature.
Conclusion: Our study has shown that rapid HBsAg kits on the Ghanaian markets may not be helpful for screening
blood donor samples. We therefore recommend the use of commercially available enzyme linked immunosorbent assays.
Keywords: Hepatitis B virus infections, Immunochromatographic kit, Sensitivity and specificity, Blood donor
samples, GhanaBackground
Hepatitis B virus (HBV) infection is the most wide-
spread, chronic viral infection globally. About two billion
(2 billion) people worldwide are affected and close to
350 million have active chronic HBV infection [1]. In
highly endemic geographical regions such as the East
and Southeast Asia, sub-Saharan Africa, and parts of
South America, over 8% of the population are chronic
carriers of HBV [2].* Correspondence: owusumichael-gh@hotmail.com
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unless otherwise stated.In Ghana, the prevalence rate of HBsAg has been re-
ported to range between 8–15% in urban areas and some
parts of rural Ghana; a scenario suggesting endemicity
of the disease [3-5]. HBV infection therefore is an
important public health concern which requires active
surveillance to be conducted in other remote rural areas
of Ghana.
Although surveillance of HBV infection is important
for both detection and exclusion of blood donors, the
utility of less sensitivity diagnostic kits could pose sig-
nificant risk to patients. In Ghana and many developing
countries, HBsAg screening is usually performed using
rapid immunochromatographic tests (ICT). This methodntral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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linked immunosorbent assays (ELISA) because ICT kits
are simple, quick, and cheaper. More so, ICT kits do not
require skilled labour and are readily available on the
markets. Another advantage of the ICT kits is their flexi-
bility in terms of using both whole blood and plasma
samples from subjects.
With an increasing population size and expansion of
blood donor facilities to rural areas, the demand for
these ICT kits has increased in Ghana and many deve-
loping countries. The scale of the influx of these ICT
kits in many developing countries makes it impossible
for adequate evaluation by state agencies such as the
food and drugs administrations. In 2003, Allain et al., re-
ported a 71% sensitivity of one brand of rapid dipstick
among blood donors in Ghana, thus suggesting the re-
sidual risk of post-transfusion [6].
Currently many other brands of HBsAg ICT kits are
on the Ghanaian market however there is insufficient
data on their sensitivity and specificity. This information
is useful as it will provide data to estimate the risk of
transfusion related HBV infection and offer recommen-
dations that will improve the quality of healthcare deli-
very in Ghana. This study was therefore undertaken to
describe the prevalence of HBV and to evaluate the per-
formance of ICT kits used in Ghana.
Methods
Type of study
A cross-sectional study was conducted to investigate the
prevalence of hepatitis B surface antigen among blood
donors and to also evaluate the performance of rapid
kits used for screening blood donors.
Study area
The cross-sectional study was carried out at the Techiman
Holy Family Hospital, located in the Techiman municipa-
lity of the Brong Ahafo region in Ghana. The hospital has
a current bed capacity of 211 and serves as the referral
hospital for all other health facilities in the Techiman mu-
nicipality and other parts of the Brong Ahafo region of
Ghana. The municipality shares common boundaries with
Wenchi district to the north-west, Kintampo south district
to the north-east, Nkoranza district to the south-east and
Offinso district in the Ashanti region to the south. The mu-
nicipality has a total land area of 669.7 square kilometers
with climate and vegetation that promotes the production
of food. In the Brong Ahafo region, the Techiman munici-
pality has the highest population density of 318 people per
square kilometer.
Study design and patient sampling
Two study designs were employed to describe the preva-
lence of HBsAg infection, identify the occurrence of HBVmarkers among subjects positive for HBsAg and also
evaluate the performance of rapid kits used for screening
hepatitis B in the northern part of Ghana.
For the cross-sectional study, a total of one hundred
and sixty four (164) blood donors; made up of voluntary
and replacement donors, were screened for HBsAg, bet-
ween the period of January, 2012 and December, 2013.
Subjects were selected if they were between 16–65 years
of age, had average weight of 50 kg, haemoglobin value
of 12.5 g/dl and blood pressure of less 140/90 mmHg.
Subjects were excluded if they were found to be physi-
cally unfit and less than the age of 16 years. Structured
questionnaires were administered to each subject se-
lected and information on their socio-demographic sta-
tus as well as possible risk factors of HBsAg exposure
was retrieved from them.
For the experimental study, five brands of kits com-
monly used by blood donation centres to screen blood
for HBsAg in the Ashanti and Brong Ahafo regional hos-
pitals were evaluated. These brands of kits were then
purchased from suppliers in the two regions and eva-
luated using ELISA as the gold standard. The evaluation
of the test kits was done using blood samples selected at
random from the cross-sectional study. Laboratory tes-
ting of the samples was carried out at the Virus Research
Laboratory of the School of Medical Sciences (SMS) of the
Kwame Nkrumah University of Science and Technology
(KNUST) in Kumasi, Ghana.
Sample collection and preparation
About 2 mls of ethylenediaminetetraacetic acid (EDTA)
treated blood samples were collected from subjects who
had reported for voluntary and replacement blood dona-
tions at the Techiman municipality. Plasma was sepa-
rated from the whole blood and stored at −20°C. At the
end of sampling, frozen plasma were transferred to the
Virus Research Laboratory of the SMS, KNUST.
Laboratory methods
All samples were screened for HBsAg using ELISA
kits (Human Gesellschaft, Biochemica and Diagnostics,
Germany).
The assay principle is based on the direct antigen
ELISA technique using microwells coated with a mo-
noclonal antibody (MAb, mouse) against HBsAg. Test
samples react simultaneously with the immobilized
MAb and with a polyclonal anti-HBs antibody (guinea
pig) conjugated with horseradish peroxidase. If HBsAg is
present in the sample, the peroxidase-containing com-
plex is captured on the microwell surface. After incuba-
tion unbound enzyme conjugate is removed by washing.
Substrate solution is added and during further incuba-
tion blue colour develops. After stopping the reaction
with acidic solution the colour changes to yellow. The
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HBsAg in the specimen.
Testing was initiated by first bringing the kit, reagent
and sera to room temperature. Testing was done accor-
ding to the manufacturer’s protocol (Human Gesellschaft,
Biochemica and Diagnostics, Germany). Briefly, the
wells of each of the microplate were labelled for blank,
controls and samples. For each batch of testing, three
negative controls and two positive controls were in-
cluded. One hundred microliters of wash buffer was pi-
petted into the blank. Fifty microliters each of negative
control, positive control and test samples were pipetted
into the appropriate wells. Fifty microliters of the conju-
gate reagent was added to each labelled well, except for
the blank. It was mixed carefully and covered with
Adhesive strips to prevent evaporation during incuba-
tion. The plates were incubated at 37°C for 80 minutes
in an incubator. After incubation, it was washed with
wash buffer for 5 times in an automatic washer. After
this step, the microwell was blot dried by inverting the
microplate and tapping firmly onto absorbent paper.
One hundred microliter of the substrate was added to
the entire microwell and mixed carefully. It was again
incubated at room temperature (15-25°C) in the dark
for 30 minutes. A stop solution of 100 μl was added
after the time duration and the samples were read using
a 450 nm filter microplate reader.
A subset of samples selected at random were further
screened for HBsAg using five HBsAg ICT kits. The test
was performed using guidelines provided by the ma-
nufacturer. Briefly, each strip was immersed in a well-
mixed plasma specimen for 10–15 seconds. The results
were read after 15–30 minutes.
Similarly, rapid HBsAg marker test was performed for
all samples positive for HBsAg tests using Wonfo
HBsAg panel test kit (Wondfo, China). The test was
performed by pipetting 50 μl of plasma unto the test
wells for 10–15 seconds. The results were read after
15–30 minutes.
Ethical approval
The study protocol was approved by the Committee for
Human Research, Publications and Ethics of Komfo
Anokye Teaching Hospital (KATH) and the School of
Medical Sciences, KNUST, Kumasi, Ashanti region,
Ghana. The protocol was first explained to every subject
that was recruited. In the case of subjects less than
18 years, the protocol was explained to their guardians
or parents. Subjects who consented to the study were
asked to either thumbprint or sign the participant con-
sent form depending on whether they were literates or
illiterates. Assent was obtained from those less than
18 years and written informed consent was obtained
from their parents or guardians.Statistical analysis
Data entry was done using spreadsheet database prepared
with Microsoft® Excel. Statistical analysis was done using
R statistical software version 3.0.2 [7]. Socio-demographic
variables such as age groups and their association with ex-
posure to HBsAg were analyzed using the Fischer’s exact
test or Chi-square test where necessary. The risk factors
associated with exposure to HBsAg were determined by
entering all variables that were significant at P < 0.1 from
the bivariate analysis into an unconditional multiple lo-
gistic regression model. A forward and backward stepwise
approach was used for selection of significant variables
from the model. Results were expressed as adjusted odd
ratios and 95% confidence interval (CI).
The sensitivities and specificities of the ICT kits were
determined by estimating the proportion of true positive
or negative test results. The reliability of the ICTs were
further assessed by determining the area under the
curve (AUC) using receiver operating characteristic
(ROC) curve. All data manipulations were done using
the EPICALC package [8] and ROC curves were plotted
using the pROC package [9]. For all analysis done, a
p-value of less than 0.05 was considered statistically
significant.
Results
Characteristics of study subjects and HBsAg detections
A total of 164 prospective blood donors were enrolled in
this study from January 2012 to December 2013. The
median age was 28 years with a minimum of 17 years
and maximum of 57 years. The number of males
enrolled was higher (95.1%) than females (4.9%). The
overall true prevalence of HBsAg (using the ELISA kit)
was 14.6 (95% CI = 9.6 – 21.0). A comparison of ELISA
tested HBsAg infections among age groups showed no
significant difference (p = 0.753).
The different socio-demographic variables were also
compared for subjects with HBsAg and those without
exposure. There was no significant difference in the fre-
quency of HBsAg for the subject’s occupation, marriage
status, religion, type of housing and level of income. The
frequency of HBsAg detection was however significant
for the level of education. Table 1 describes the sociode-
mographic factors and their association with HBsAg
detection.
The factors associated with exposure to HBsAg were
also determined by comparing the proportion of HBsAg
detections for subjects with history of drug use, intra-
venous drug use, tattoos, number of sexual partners and
family history of liver disease. There was no significant
association between HBsAg detections and the various
factors (Table 2). The odds of exposure to hepatitis B
was determined by entering all variables with p-value
less than 0.1 into a logistic regression model. All
Table 1 Socio-demography of subjects with HBsAg positivity
Subject information HBsAg status
Positive (%) Negative (%) Total (%) P-value
24(14.6) 140(85.4) 164(100)
Occupation of subjects Farming 9(37.5) 30(21.4) 39(23.8) 0.527
Teaching 0(0) 6(4.3) 6(3.7)
Trading 3(12.5) 26(18.6) 29(17.7)
Unemployed 1(4.2) 12(8.6) 13(7.9)
Other 11(45.8) 66(47.1) 77(47)
Marital status of subjects Married 15(62.5) 68(48.6) 83(50.6) 0.298
Single 9(37.5) 72(51.4) 81(49.4)
Religion of subjects Christian 16(66.7) 112(80) 128(78) 0.334
Islamic 6(25) 19(13.6) 25(15.2)
Traditional 0(0) 2(1.4) 2(1.2)
None 2(8.3) 7(5) 9(5.5) 0.334
Level of education of subjects Illiterate 4(16.7) 11(7.9) 15(9.1) 0.028
Junior 7(29.2) 56(40) 63(38.4)
Primary 9(37.5) 22(15.7) 31(18.9)
Secondary 4(16.7) 35(25) 39(23.8)
Tertiary 0(0) 16(11.4) 16(9.8)
Type of housing of subjects compound 14(58.3) 105(75) 119(72.6) 0.149
Self-contained 10(41.7) 35(25) 45(27.4)
Average income level of subjects 50 0(0) 10(7.1) 10(6.1) 0.208
80 7(29.2) 57(40.7) 64(39.0)
100 12(50.0) 54(38.6) 66(40.2)
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attended primary school (adjusted OR = 3.05, p-value =
0.051) which was slightly at the probability borderline.
Hepatitis B virus serological markers
HBV serological markers or biomarkers were evaluated
for all study subjects who tested positive for HBsAg.
The occurrence of biomarkers such as HBeAg, HBeAb,
HBcAb and HBsAb were determined using rapid hepa-
titis B panel tests. Of the 24 subjects positive for HBsAg,
13 (54.2%) were HBcAb positive, 5 (20.8%) were HBeAb
positive, 4 (16.7%) were HBeAg positive and 1 (4.2%)
were HBsAb positive.
Sensitivity and specificity of rapid kits
We evaluated the performance of the most common
ICT kits used for screening blood donors in some blood
bank facilities in the northern part of Ghana using the
clinical samples. The sensitivity and specificity of the five
ICT kits identified in the various blood bank facilities
were determined using the ELISA technique as the gold
standard. The rapid kit evaluation was done on the 150
samples selected at random that had already been testedusing the ELISA technique. Only 150 of the 164 samples
were selected for evaluation because of the limited re-
sources available. The proportions of HBsAg that were
positive for all rapid kits are as follows: Abon = 8%,
Acull-Tell = 8.7%, Rapid care = 8.7%, Core TM= 8.7%
and Wondfo = 9.3%. Kappa test for Wondfo was 68.7%,
followed by Accul-Tell =64.7%, Care Rapid = 64.7%, Core
Tm = 58.3% and then Abon = 60.6%. The Youden’s in-
dexes for all five rapid kits were below 60%. The kit with
the highest Youden’s index was Wondfo and the one
with the lowest was Core Tm. All kits showed specifi-
cities and positive predictive values of more than 90%. A
comparison of the performance of the rapid kits to
ELISA method is shown in Table 3.
To further assess the reliability of the test kits, we deter-
mined the area under the curve (AUC) for each diagnostic
kit and also plotted the receiver operating characteristic
(ROC) curve. Wondfo kit had the highest AUC (0.792;
95% CI = 0.686 – 0.897) followed by Acull-Tell (0.769;
95% CI = 0.662 – 0.876) and Care Rapid (0.769; 0.662 –
0.876), Abon kit (0.746; 95% CI = 0.640 – 0.853) and then
Core TM (0.742; 95% CI = 0.635 – 0.850). Figure 1 shows
the ROC curves for each rapid kit.
Table 2 Factors associated with HBsAg exposure
Risk of exposure to HBsAg HBsAg
Positive no. (%) Negative no. (%) Total no. (%) P-value
24(14.6) 140(85.4) 164(100)
Subjects with history of blood transfusion No 23(95.8) 138(98.6) 161(98.2) 0.38
Yes 1(4.2) 2(1.4) 3(1.8)
Subjects who use IV drugs currently No 24(100) 138(98.6) 162(98.8) 1
Yes 0(0) 2(1.4) 2(1.2)
Subjects with history of IV drug use No 23(95.8) 135(96.4) 158(96.3) 1
Yes 1(4.2) 5(3.6) 6(3.7)
Subject with current tattoos No 23(95.8) 139(99.3) 162(98.8) 0.275
Yes 1(4.2) 1(0.7) 2(1.2)
Subject with history of tattoo No 23(95.8) 138(98.6) 161(98.2) 0.38
Yes 1(4.2) 2(1.4) 3(1.8)
Subjects with history of STI No 23(95.8) 132(94.3) 155(94.5) 1
Yes 1(4.2) 8(5.7) 9(5.5)
Subjects with history of surgery No 24(100) 136(97.1) 160(97.6) 1
Yes 0(0) 4(2.9) 4(2.4)
Number of sexual partners of subjects More than one 6(25) 20(14.3) 26(15.9) 0.102
None 4(16.7) 12(8.6) 16(9.8)
One 14(58.3) 108(77.1) 122(74.4)
Subject with family relatives having hepatitis No 24(100) 135(96.4) 159(97) 1
Yes 0(0) 5(3.6) 5(3)
Subject with family relative having liver disease No 24(1000 137(97.9) 161(98.2) 1
Yes 0(0) 3(2.1) 3(1.8)
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rapid kits
To further explore the performance of the rapid kits, we
compared the reported sensitivities and specificities of
the Accutell, Wondfo and Abon kits to results generated
by this study. This comparison was done for only the
three kit brands because the other kits did not have
accompanying information of the kit performance in the
kit inset. The three ICT kits (Accutell, Wondfo and
Abon) specificities were comparable to the study results
since the values fell within the confidence intervals of
our specificity results. The rapid kit sensitivity values
however differed significantly from the study results.Table 3 Comparative sensitivity and specificity of rapid HBsA
Test kit Sensitivity Specificity PPV
(95% CI) (95% CI) (95% CI)
Wondfo 59.1(36.4 - 79.3) 99.3(95.7 - 100.0) 92.9(66.1 -
Accul-Tell 54.5(32.2 - 75.6) 99.2(95.7 - 100) 92.3(64.0 -
Care Rapid 54.5(32.2 - 75.6) 99.3(95.7 - 100) 92.3(64–9
Core Tm 50(28.2 - 71.8) 98.4(94.5 - 99.8) 84.6(54.5 -
Abon 50(28–71.8 99.2(95.7 - 100) 91.7(61.5 -
NPV: Negative Predictive Value, PPV: Positive Predictive Value.Table 4 shows a comparison of the reported values of
the three ICT kits compared to the results generated by
this study.
Discussion
Hepatitis B viral infection continues to pose a major
threat in many developing countries including Ghana.
Few studies have attempted to describe the prevalence
of HBsAg among blood donors in different parts of
Ghana [4,5]. These estimates were however based on the
use of HBsAg rapid kits which could underestimate the
prevalence of HBsAg infection. Using an ELISA based
method (recommended gold standard); the present studyg kit using HBsAg ELISA as gold standard
NPV Youden's index Kappa test
(95% CI) (95% CI) (%)
99.8) 93.4(87.8 - 96.9) 58.3(32.1 - 79.3) 68.7
99.8) 92.7(87.0 - 96.4) 53.8(27.9 - 75.6) 64.7
9.8) 92.7(87.0 - 96.4) 53.8(27.9 - 75.6) 64.7
98.1) 92.0(86.1 - 95.9) 48.4(22.7 - 71.6) 58.3

























Figure 1 Receiver operating characteristic curves for five immunochromatographic kits. The x-axis shows the values for 1-specificity and
the y axis, the values for sensitivity. The curves for the respective kits are as follows: Wondfo - black line, Abon - red dash line, Acul-Tell - green
dotted line, Care Rapid - blue dash line and Core Tm - Cyan dash line.
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and replacement blood donors in a rural area of Ghana.
This prevalence rate is similar to a previous study done
in an urban area of Ghana using an ELISA based assay
[3], but higher compared to reported prevalences in
some developing and developed countries [10-13].
The seeming high prevalence of HBV infection among
Ghanaians could possibly suggest that not much is being
done in terms of immunization and public health educa-
tion of the population against the risk of transmission.
This situation is likely to be prominent among individuals
in rural areas where the level of poverty is very high and
individuals may not be able to afford 3 shots of hepatitis B




Sensitivity (%) Specificity (%)
Wondfo 96.2 99.3
Accutell 98.89 98.87
Abon Kit 99% 97%
NB: Values for rapid HBsAg Care and Core TM were not provided in the kit inset.in Ghana has included hepatitis B vaccine as part of the
childhood vaccines given to newborns, the seeming neg-
lect of the adult population needs to be looked at in order
to reduce the risk of transfusion related infections. The
low prevalence rates in the developed countries
are due to effective immunization and public health edu-
cation [14].
In order to evaluate the hepatitis B status of blood do-
nors, the proportion of subjects who tested positive
for HBsAg were screened for other serological markers
(HBeAg, HBeAb and HBcAb). Our results showed a
16.7% prevalence rate of HBeAg. This is higher com-
pared to studies done in other African countries [15,16]
but similar to a previous study in Ghana [17].g kits
Actual Actual
Sensitivity (95% CI) Specificity (95% CI)
59.1(36.4 - 79.3) 99.3(95.7 - 100.0)
54.5(32.2 - 75.6) 99.2(95.7 - 100)
50(28–71.8) 99.2(95.7 - 100)
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replicative state of the virus and the high occurrence of
this marker among HBV infected subjects could suggest
that a significant proportion of the population have
active HBV infections.
This could have devastating public health consequences
if adequate measures are not taken to reduce HBV infec-
tions in Ghana. There is therefore the need for adequate
public health education and vaccination interventions to
reduce the risk of hepatitis B virus infections.
One unique finding of this study was the poor per-
formance of all five rapid ICT kits that were evaluated.
ICT kits are now widely used for quick screening of
blood donors in developing countries. This method can
be completed in 10–20 minutes and requires less skilled
personnel for the test to be performed. It is also not ex-
pensive and hence easily used in rural and peri-urban
areas for screening of blood donors. However, the influx
of various brands of these kits in the Ghanaian market
without subject to appropriate quality testing is worri-
some and could pose risk to the health of the entire
country. All five test kits evaluated in this study had sen-
sitivities of around 50-59% with poor kappa statistics of
round 60%. This poor kit performance could be due to a
number of reasons such as poor storage conditions or
low detection limits. We however ruled out the possi-
bility of poor storage at the transfusion/testing centres
by buying the kit brand directly from suppliers for the
study. We therefore believe such poor performance of
the kits could be due to low detection limits of kits de-
signed by manufacturers or poor conditions of transport
and storage of the kits by importers and retailers. Inter-
estingly the reported sensitivities from the kit insets of
some of the rapid kits varied significantly from results of
our study. This could possibly suggest an inaccurate in-
formation or deception of the public by manufacturers
of these kits.
Our results are not too different from other studies re-
ported in Ghana [6,18]. Allain et al. [6] previously re-
ported low sensitivity of both latex agglutination and
rapid dipstick compared to ELISA and PCR methods [6].
They further explained that the low sensitivity of rapid
dipsticks were probably due to the low viral load of
hepatitis virus among chronic carriers. In spite of this in-
formation being available almost over a decade now,
many blood donation centres still rely on less sensitive
rapid kits as a screening tool. One possible reason why
these kits are massively patronised by Ghanaian health
facilities is because of the low cost. The question we ask
ourselves is should cost serve as determining factor in
purchasing screening kits in Ghana? We believe it is im-
portant that appropriate kits which are sensitive and
specific be used to screen blood donors so as to reduce
the risk of transmission of hepatitis B virus infections.One major limitation of the study is the small sample
size of our study subjects. This was due to logistic con-
straints. We therefore recommend that future studies be
performed on larger population size and other brands of
HBsAg rapid kits be also evaluated.
In conclusion, rapid test kits or ICT kits for HBsAg
may not be helpful for screening blood donor samples in
Ghana due to its low sensitivity. We therefore recom-
mend using them as first line screening kits and further
confirming all negative samples using commercially
available ELISA kits. The influx of rapid kits on the mar-
ket should also be adequately controlled and evaluated
by the standards authority to ensure that they are of
high quality. These interventions if adopted could help
protect the public against transfusion related infectious
diseases.
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